PF-04859989 as a template for structure-based drug design: identification of new pyrazole series of irreversible KAT II inhibitors with improved lipophilic efficiency
about
Kynurenines in CNS disease: regulation by inflammatory cytokinesKynurenine Aminotransferase Isozyme Inhibitors: A ReviewStructural Basis for Substrate Specificity in ArnB. A Key Enzyme in the Polymyxin Resistance Pathway of Gram-Negative BacteriaA systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of ratsMajor developments in the design of inhibitors along the kynurenine pathway.Structure of the PLP-Form of the Human Kynurenine Aminotransferase II in a Novel Spacegroup at 1.83 Å Resolution.Targeting kynurenine aminotransferase II in psychiatric diseases: promising effects of an orally active enzyme inhibitor.Cyclic Hydroxamic Acid Analogues of Bacterial Siderophores as Iron-Complexing Agents prepared through the Castagnoli-Cushman Reaction of Unprotected Oximes.Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex.
P2860
Q21129356-7E765DAC-F6FE-4390-8870-8BFECEC387DFQ26744492-A0D14494-F52D-4C29-A153-619FCA375B3AQ27681447-B3EB9DB9-9083-4BA9-A023-CA8C4798A4FFQ35213516-7B4AA45D-2B52-4CE6-90D7-372037EB23A5Q38808400-8809324A-D238-41AA-900E-47ABD67CE2A9Q40749076-A7C8B6D8-FCFC-4F40-8A38-6E46C831F3ADQ41977343-5CE64B4B-9186-4EA7-B422-A5C553398F0DQ48125253-ECFEBAAD-7AC2-46B4-97C6-ED0FB273C027Q50331698-478AB58D-2AF8-47EE-AEBD-AEC046D3CA1F
P2860
PF-04859989 as a template for structure-based drug design: identification of new pyrazole series of irreversible KAT II inhibitors with improved lipophilic efficiency
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
PF-04859989 as a template for ...... improved lipophilic efficiency
@ast
PF-04859989 as a template for ...... improved lipophilic efficiency
@en
PF-04859989 as a template for ...... improved lipophilic efficiency
@nl
type
label
PF-04859989 as a template for ...... improved lipophilic efficiency
@ast
PF-04859989 as a template for ...... improved lipophilic efficiency
@en
PF-04859989 as a template for ...... improved lipophilic efficiency
@nl
prefLabel
PF-04859989 as a template for ...... improved lipophilic efficiency
@ast
PF-04859989 as a template for ...... improved lipophilic efficiency
@en
PF-04859989 as a template for ...... improved lipophilic efficiency
@nl
P2093
P3181
P1476
PF-04859989 as a template for ...... improved lipophilic efficiency
@en
P2093
Amy B Dounay
Bruce M Bechle
Edelweiss Evrard
Jamison B Tuttle
Ji-Young Kim
Laura A McAllister
Laura E Zawadzke
Marie Anderson
Michelle A Salafia
Patrick R Verhoest
P304
P3181
P356
10.1016/J.BMCL.2013.02.039
P407
P577
2013-04-01T00:00:00Z